Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy

被引:0
|
作者
Berrin Gunaydin
Zerrin Ozkose
Seyda Pezek
机构
[1] Gazi University,Department of Anesthesiology and Reanimation, Faculty of Medicine
来源
Journal of Anesthesia | 2007年 / 21卷
关键词
Tranexamic Acid; Recombinant Factor VIIa; Vecuronium Bromide; Novoseven; Thiopentone Sodium;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:106 / 107
页数:1
相关论文
共 50 条
  • [1] Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy
    Gunaydin, Berrin
    Ozkose, Zerrin
    Pezek, Seyda
    JOURNAL OF ANESTHESIA, 2007, 21 (01) : 106 - 107
  • [2] Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"
    Keikhaei, Bijan
    HAEMOPHILIA, 2014, 20 : 101 - 102
  • [3] The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
    Poon, Man-Chiu
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 332 - 340
  • [4] Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature
    Rajpurkar, M.
    Chitlur, M.
    Recht, M.
    Cooper, D. L.
    HAEMOPHILIA, 2014, 20 (04) : 464 - 471
  • [5] Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report
    Bisinotto, Flora Margarida Barra
    Martins, Laura Bisinotto
    de Camargos, Giovanini Pires
    Bianco, Marcelo de Paula
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2022, 72 (06): : 823 - 825
  • [6] Experience of recombinant-activated factor VII to control bleeding in children with Glanzmann’s thrombasthenia
    Khair K.
    Svirin P.
    Comparative Clinical Pathology, 2007, 16 (3) : 167 - 172
  • [7] Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia
    Lombardo, VT
    Sottilotta, G
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (01) : 115 - 116
  • [8] Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review
    Saultier, Paul
    Grino, Michel
    Falaise, Celine
    Voisin, Sophie
    Lavenu-Bombled, Cecile
    Ibrahim-Kosta, Manal
    Petit, Audrey
    Boutroux, Helene
    Desprez, Dominique
    Fiore, Mathieu
    d'Oiron, Roseline
    Alessi, Marie-Christine
    HAEMOPHILIA, 2025, 31 (01) : 7 - 15
  • [9] EVALUATION OF THE EFFICACY AND SAFETY OF A HUMAN RECOMBINANT ACTIVATED FACTOR VII (HRFVIIA) PREPARATION IN A PEDIATRIC PATIENT WITH GLANZMANN THROMBASTHENIA
    Szamosujvari, J.
    Losonczy, G.
    Muszbek, L.
    Kappelmayer, J.
    Kiss, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 526 - 527
  • [10] Use of recombinant factor VII in Glanzmann thrombasthenia: A case report
    Ben Abdallah, R. Chabchoub
    Trabelsi, L.
    Ben Ameur, S.
    Kammoun, F.
    Boukedi, A.
    Ben Salah, M.
    Ben Hlima, N.
    Mahfoudh, A.
    ARCHIVES DE PEDIATRIE, 2010, 17 (07): : 1062 - 1064